Effects of natural ligands of PPARγ on lipid metabolism in placental tissues from healthy and diabetic rats

Molecular Human Reproduction

Volumn 14, Issue 8, 2008, Pages 491-499

  Capobianco, Evangelina ^a   White, Verónica ^a   Higa, Romina ^a   Martínez, Nora ^a   Jawerbaum, Alicia ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Diabetes in pregnancy; Lipids; Placenta; PPARs; Prostaglandins

Indexed keywords

CHOLESTEROL ESTER; FATTY ACID; OLIVE OIL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PHOSPHOLIPID; PROSTAGLANDIN J2; SAFFLOWER OIL; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; FEMALE; FETOMATERNAL TRANSFUSION; FETUS CIRCULATION; IN VITRO STUDY; IN VIVO STUDY; LIPID METABOLISM; LIPOGENESIS; NONHUMAN; PLACENTA; PLACENTA FUNCTION; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIETARY FATS; DISEASE MODELS, ANIMAL; FEMALE; FETAL WEIGHT; IMMUNOENZYME TECHNIQUES; LIPID METABOLISM; MALE; PLACENTA; PPAR GAMMA; PREGNANCY; PROSTAGLANDIN D2; RANDOM ALLOCATION; RATS; RATS, WISTAR;

CARTHAMUS TINCTORIUS; RATTUS;

EID: 49649119987     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gan039     Document Type: Article

References (53)

1. Ackerman WET, Zhang XL, Rovin BH, Kniss DA. Modulation of cytokine-induced cyclooxygenase 2 expression by PPARG ligands through NFkappaB signal disruption in human WISH and amnion cells. Biol Reprod 2005;73:527-535.
2. Ain R, Konno T, Canham LN, Soares MJ. Phenotypic analysis of the rat placenta. Methods Mol Med 2006;121:295-313.
3. Amusquivar E, Herrera E. Influence of changes in dietary fatty acids during pregnancy on placental and fetal fatty acid profile in the rat. Biol Neonate 2003;83:136-145.
4. Asami-Miyagishi R, Iseki S, Usui M, Uchida K, Kubo H, Morita I. Expression and function of PPARgamma in rat placental development. Biochem Biophys Res Commun 2004;315:497-501.
5. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, Evans RM. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 1999;4:585-595.
6. Barlic J, Murphy PM. An oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophagevascular smooth muscle cell adhesion. Trends Cardiovasc Med 2007;17 269-274.
7. Beaven SW, Tontonoz P. Nuclear receptors in lipid metabolism: Targeting the heart of dyslipidemia. Annu Rev Med 2006;57:313-329.
8. Bildirici I, Roh CR, Schaiff WT, Lewkowski BM, Nelson DM, Sadovsky Y. The lipid droplet-associated protein adipophilin is expressed in human trophoblasts and is regulated by peroxisomal proliferator-activated receptor-gamma/retinoid X receptor. J Clin Endocrinol Metab 2003;88:6056-6062.
9. Capobianco E, Jawerbaum A, Romanini MC, White V, Pustovrh C, Higa R, Martinez N, Mugnaini MT, Sonez C, Gonzalez E. 15-Deoxy-Delta(12,14)-prostaglandin J2 and peroxisome proliferator-activated receptor gamma (PPARgamma) levels in term placental tissues from control and diabetic rats: Modulatory effects of a PPARgamma agonist on nitridergic and lipid placental metabolism. Reprod Fertil Dev 2005;17:423-433.
10. Catalano PM, Kirwan JP. Maternal factors that determine neonatal size and body fat. Curr Diab Rep 2001;1:71-77.
11. Council SoLANNR. Nutrient requirements of the laboratory rat. Nutrient Requirements of Laboratory Animals. Washington, DC: National Academy Press, 1995, 11-79.
12. Desmarais JA, Lopes FL, Zhang H, Das SK, Murphy BD. The peroxisome proliferator-activated receptor gamma regulates trophoblast cell differentiation in mink (Mustela vison). Biol Reprod 2007;77 829-839.
13. Desoye G, Shafrir E. Placental metabolism and its regulation in health and diabetes. Mol Aspects Med 1994;15:505-682.
14. Desvergne B, Michalik L, Wahli W. Be fit or be sick: Peroxisome proliferator-activated receptors are down the road. Mol Endocrinol 2004;18:1321-1332.
15. Diamant YZ. The human placenta in diabetes mellitus. Isr J Med Sci 1991;27:493-497.
16. Duttaroy AK. Fetal growth and development: Roles of fatty acid transport proteins and nuclear transcription factors in human placenta. Indian J Exp Biol 2004;42:747-757.
17. Eriksson UJ, Cederberg J, Wentzel P. Congenital malformations in offspring of diabetic mothers-animal and human studies. Rev Endocr Metab Disord 2003;4:79-93.
18. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 1995;83:803-812.
19. Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA 1997;94 4312-4317.
20. Fournier T, Handschuh K, Tsatsaris V, Evain-Brion D. Involvement of PPARgamma in human trophoblast invasion. Placenta 2007a;28 Suppl A): S76-S81.
21. Fournier T, Tsatsaris V, Handschuh K, Evain-Brion D. PPARs and the placenta. Placenta 2007b;28:65-76.
22. Haggarty P. Placental regulation of fatty acid delivery and its effect on fetal growth - a review. Placenta 2002;23(Suppl A):S28-S38.
23. Herrera E, Amusquivar E. Lipid metabolism in the fetus and the newborn. Diabetes Metab Res Rev 2000;16:202-210.
24. Herrera E, Amusquivar E, Lopez-Soldado I, Ortega H. Maternal lipid metabolism and placental lipid transfer. Horm Res 2006;65 Suppl 3): 59-64.
25. Higa R, Gonzalez E, Pustovrh MC, White V, Capobianco E, Martinez N, Jawerbaum A. PPARdelta and its activator PGI2 are reduced in diabetic embryopathy: Involvement of PPARdelta activation in lipid metabolic and signalling pathways in rat embryo early organogenesis. Mol Hum Reprod 2007;13:103-110.
26. Hihi AK, Michalik L, Wahli W. PPARs: Transcriptional effectors of fatty acids and their derivatives. Cell Mol Life Sci 2002;59 790-798.
27. Jawerbaum A, Gonzalez E. The role of alterations in arachidonic acid metabolism and nitric oxide homeostasis in rat models of diabetes during early pregnancy. Curr Pharm Des 2005;11:1327-1342.
28. Jawerbaum A, Gonzalez E. Diabetic pregnancies: The challenge of developing in a pro-inflammatory environment. Curr Med Chem 2006; 13:2127-2138.
29. Jawerbaum A, Sinner D, White V, Pustovrh C, Capobianco E, Gonzalez E. Modulation of nitric oxide concentration and lipid metabolism by 15-deoxy Delta12,14prostaglandin J2 in embryos from control and diabetic rats during early organogenesis. Reproduction 2002;124 625-631.
30. Jawerbaum A, Capobianco E, Pustovrh C, White V, Baier M, Salzberg S, Pesaresi M, Gonzalez E. Influence of peroxisome proliferator-activated receptor gamma activation by its endogenous ligand 15-deoxy Delta12,14 prostaglandin J2 on nitric oxide production in term placental tissues from diabetic women. Mol Hum Reprod 2004;10:671-676.
31. Kersten S, Wahli W. Peroxisome proliferator activated receptor agonists. EXS 2000;89:141-151.
32. Kitzmiller JL, Cloherty JP, Younger MD, Tabatabaii A, Rothchild SB, Sosenko I, Epstein MF, Singh S, Neff RK. Diabetic pregnancy and perinatal morbidity. Am J Obstet Gynecol 1978;131:560-580.
33. Krishnamachar S, Canolty NL. Influence of diet composition on intake and utilization of protein and energy in diabetic and control rats. J Nutr 1986;116:461-471.
34. Lappas M, Permezel M, Georgiou HM, Rice GE. Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-gamma: Effect of 15-deoxy-Delta(12,14)-PGJ(2) and troglitazone. J Clin Endocrinol Metab 2002;87:4667-4672.
35. Lee CH, Olson P, Evans RM. Minireview: Lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 2003;144:2201-2207.
36. Portha B, Picon L, Rosselin G. Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes. Diabetologia 1979; 17:371-377.
37. Radaelli T, Varastehpour A, Catalano P, Hauguel-de Mouzon S. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes 2003;52:2951-2958.
38. Reece EA, Eriksson UJ. The pathogenesis of diabetes-associated congenital malformations. Obstet Gynecol Clin North Am 1996;23 29-45.
39. Reece EA, Wu YK, Wiznitzer A, Homko C, Yao J, Borenstein M, Sloskey G. Dietary polyunsaturated fatty acid prevents malformations in offspring of diabetic rats. Am J Obstet Gynecol 1996;175:818-823.
40. Saldeen P, Olofsson P, Laurini RN. Structural, functional and circulatory placental changes associated with impaired glucose metabolism. Eur J Obstet Gynecol Reprod Biol 2002;105 136-142.
41. Schaiff WT, Bildirici I, Cheong M, Chern PL, Nelson DM, Sadovsky Y. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor signaling regulate fatty acid uptake by primary human placental trophoblasts. J Clin Endocrinol Metab 2005;90:4267-4275.
42. Schaiff WT, Barak Y, Sadovsky Y. The pleiotropic function of PPAR gamma in the placenta. Mol Cell Endocrinol 2006;249:10-15.
43. Schaiff WT, Knapp FF, Jr, Barak Y, Biron-Shental T, Nelson DM, Sadovsky Y. Ligand-activated peroxisome proliferator activated receptor gamma alters placental morphology and placental fatty acid uptake in mice. Endocrinology 2007;148:3625-3634.
44. Scher JU, Pillinger MH. 15d-PGJ2: The anti-inflammatory prostaglandin? Clin Immunol 2005;114:100-109.
45. Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J lipid Res 1996; 37:907-925.
46. Schroeder F, Petrescu, AD, Huang H, Atshaves BP, McIntosh AL, Martin GG, Hostetler HA, Vespa A, Landrock D, Landrock KK et al. Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription. Lipids 2008;43 1-17.
47. Schwartz R, Teramo KA. Effects of diabetic pregnancy on the fetus and newborn. Semin Perinatol 2000;24:120-135.
48. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996;271:33157-33160.
49. Straus DS, Glass CK, Cyclopentenone prostaglandins: New insights on biological activities and cellular targets. Med Res Rev 2001;21 185-210.
50. Van Assche FA, Holemans K, Aerts L. Long-term consequences for offspring of diabetes during pregnancy. Br Med Bull 2001;60:173-182.
51. White V, Gonzalez E, Capobianco E, Pustovrh C, Sonez C, Romanini MC, Jawerbaum A. Modulatory effect of leptin on nitric oxide production and lipid metabolism in term placental tissues from control and streptozotocin-induced diabetic rats. Reprod Fertil Dev 2004;16 363-372.
52. Xu L, Han C, Wu T. A novel positive feedback loop between peroxisome proliferator-activated receptor-delta and prostaglandin E2 signaling pathways for human cholangiocarcinoma cell growth. J Biol Chem 2006; 281:33982-33996.
53. Xu Y, Wang Q, Cook TJ, Knipp GT. Effect of placental fatty acid metabolism and regulation by peroxisome proliferator activated receptor on pregnancy and fetal outcomes. J Pharm Sci 2007;96 2582-2606.